Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Shanghai Pharmaceuticals Holding Co ( (HK:2607) ).
Shanghai Pharmaceuticals Holding Co., Ltd. has announced an interim cash dividend of RMB 1.2 per 10 shares for the six months ending June 30, 2025, with an ex-dividend date of December 29, 2025. This announcement reflects the company’s ongoing commitment to shareholder returns and may influence its market positioning by highlighting its financial health and strategic focus on rewarding investors.
The most recent analyst rating on (HK:2607) stock is a Buy with a HK$13.00 price target. To see the full list of analyst forecasts on Shanghai Pharmaceuticals Holding Co stock, see the HK:2607 Stock Forecast page.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is a significant player in the Chinese market, offering a range of medical and healthcare solutions.
Average Trading Volume: 3,082,500
Technical Sentiment Signal: Buy
Current Market Cap: HK$66.15B
Learn more about 2607 stock on TipRanks’ Stock Analysis page.